This year, ASCs can perform and be paid for hundreds of additional procedures.
JOINT SUPPLEMENT CMS will now pay for total hip replacements performed at ASCs.
CMS’s Outpatient Prospective Payment System and Ambulatory Surgical Center final rule, which took effect on January 1, further blurs the lines between inpatient and outpatient surgical care, as well as between ASCs and HOPDs within the outpatient sphere.
The big news is the gradual elimination of the inpatient-only procedure list. This year, CMS has removed a total of 298 mostly musculoskeletal procedures from that list, and now will pay for them in HOPD settings when clinically appropriate. By 2024, the remaining 1,400 or so procedures on the inpatient-only list will be removed. Read more
https://www.endosound.com/wp-content/uploads/2021/01/endosound-blog-header.jpg300835KG-Endosoundhttp://www.endosound.com/wp-content/uploads/2023/08/Endosound-New-web-logo-no-tag2023.pngKG-Endosound2021-03-22 10:56:512021-05-16 16:28:48CMS Will Eliminate Inpatient-Only Procedure List by 2024
EndoSound’s endoscopic ultrasound device underwent a successful evaluation in a live animal (pig) lab. The evaluator was Dr. Carlos Robles-Mendanda, an internationally known expert in the field and key opinion leader to major endoscope and equipment manufacturers. He used the device without preparation or instruction. The results of the two hour evaluation included:
The images were judged “excellent”, superior to the Olympus EUM-E1 competitive device
The ability to perform a diagnostic EUS examination was judged “perfect”
Doppler capability was “very good”
The ability to adapt to utilizing a new technology was judged “easy”
The addition of the EUS device to a standard endoscope did not affect the flexibility or maneuverability of the scope
In summary, the device was judged “fantastic”, “ready”, and “a final product”.
On June 1, 2020 — EndoSound incorporates as a Delaware C Corporation
Founded by gastroenterologist Stephen Steinberg, M.D., and bioengineer Scott Corbett, EndoSound is developing affordable, safer Endoscopic Ultrasound (EUS) systems for diagnosing and treating pancreatic cancer and other diseases of the digestive tract. EUS combines endoscopy (a visual modality using video imaging) and ultrasound to create images of the digestive tract and its surrounding organs and tissues.
https://www.endosound.com/wp-content/uploads/2021/01/endosound-blog-header.jpg300835KG-Endosoundhttp://www.endosound.com/wp-content/uploads/2023/08/Endosound-New-web-logo-no-tag2023.pngKG-Endosound2020-06-01 18:06:322021-05-18 19:20:18EndoSound Incorporates as a Delaware C Corporation
CMS Will Eliminate Inpatient-Only Procedure List by 2024
General News, Industry NewsThis year, ASCs can perform and be paid for hundreds of additional procedures.
CMS’s Outpatient Prospective Payment System and Ambulatory Surgical Center final rule, which took effect on January 1, further blurs the lines between inpatient and outpatient surgical care, as well as between ASCs and HOPDs within the outpatient sphere.
The big news is the gradual elimination of the inpatient-only procedure list. This year, CMS has removed a total of 298 mostly musculoskeletal procedures from that list, and now will pay for them in HOPD settings when clinically appropriate. By 2024, the remaining 1,400 or so procedures on the inpatient-only list will be removed. Read more
December 4, 2020 — EndoSound Completes Successful Animal Study
Company NewsEndoSound’s endoscopic ultrasound device underwent a successful evaluation in a live animal (pig) lab. The evaluator was Dr. Carlos Robles-Mendanda, an internationally known expert in the field and key opinion leader to major endoscope and equipment manufacturers. He used the device without preparation or instruction. The results of the two hour evaluation included:
In summary, the device was judged “fantastic”, “ready”, and “a final product”.
EndoSound Incorporates as a Delaware C Corporation
Company NewsOn June 1, 2020 — EndoSound incorporates as a Delaware C Corporation
Founded by gastroenterologist Stephen Steinberg, M.D., and bioengineer Scott Corbett, EndoSound is developing affordable, safer Endoscopic Ultrasound (EUS) systems for diagnosing and treating pancreatic cancer and other diseases of the digestive tract. EUS combines endoscopy (a visual modality using video imaging) and ultrasound to create images of the digestive tract and its surrounding organs and tissues.